Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions (Q43766048)

26 November 2017

title

Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions (English)

1 reference

26 November 2017

0 references

Peacock L

1 reference

26 November 2017

Gerlach J

series ordinal

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

published in

Biological Psychiatry

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

501-509

1 reference

Dopamine receptor subtypes: beyond the D1/D2 classification

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

D1 receptor antagonists in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Molecular diversity of the dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Molecular cloning and expression of the gene for a human D1 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Recent advances in the molecular biology of dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Effects of chronic discontinuous and continuous treatment of rats with a dopamine D1 receptor antagonist (NNC-756)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of parkinson's disease — the differential effects of D1 dopamine antagonists in the primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Drug-induced oral dyskinesias in rats after traditional and new neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Coupling of Dopamine D 1 Recognition Sites with Adenylate Cyclase in Nuclei Accumbens and Caudatus of Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Comparative distributions of dopamine D-1 and D-2 receptors in the cerebral cortex of rats, cats, and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

A phosphoinositide-linked dopamine D1 receptor mediates repetitive jaw movements in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Induction of oral dyskinesias in naive rats by D1 stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Dopamine receptor pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

The central effects of a novel dopamine agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Molecular biology of dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901189-1

10.1016/S0006-3223(01)01189-1

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference